What is HKMA Transaction Reporting?
HKMA Transaction Reporting is Hong Kong’s regulatory framework for reporting specified OTC derivatives transactions to the Hong Kong Trade Repository (HKTR). It is designed to enhance market transparency, strengthen regulatory oversight and support the monitoring of systemic risk.
About HKMA Derivative Transaction Reporting
The Hong Kong Monetary Authority (HKMA) introduced Hong Kong's OTC derivatives reporting regime under the Securities and Futures Ordinance (SFO) as part of Hong Kong's commitment to the G20 reforms following the global financial crisis. The regime forms part of Hong Kong's wider OTC derivatives regulatory framework and is designed to improve transparency in the OTC derivatives market, strengthen regulatory oversight and enhance the monitoring of systemic risk.
Under the HKMA Reporting Rules, specified OTC derivatives transactions must be reported to the Hong Kong Trade Repository (HKTR), Hong Kong's designated trade repository for OTC derivatives. The reporting requirements cover a broad range of OTC derivatives, including interest rate, foreign exchange, credit, equity and commodity derivatives.
HKMA Rewrite
The HKMA Rewrite modernised Hong Kong's OTC derivatives reporting regime by introducing globally harmonised reporting standards, including the ISO 20022 XML reporting standard, the CPMI-IOSCO Critical Data Elements (CDE), the Unique Transaction Identifier (UTI) and the Unique Product Identifier (UPI). The changes were designed to improve data quality, consistency and timeliness, strengthen regulatory oversight, and align Hong Kong with other major OTC derivatives reporting regimes, including EMIR, ASIC, MAS and JFSA.
The HKMA Rewrite came into effect on 29 September 2025, introducing a modernised reporting framework aligned with international data and messaging standards.
Key Features
The current HKMA reporting framework incorporates both the original reporting obligations and the enhancements introduced under the HKMA Rewrite. Key features include:
- Reporting of OTC derivatives transactions.
- Reports submitted to the Hong Kong Trade Repository (HKTR), Hong Kong's designated trade repository for OTC derivatives.
- Double-sided reporting regime (counterparty-specific reporting obligations)/ each prescribed reporting entity has its own reporting obligation.
- T+2 reporting deadline for reportable OTC derivatives transactions and subsequent lifecycle events.
- ISO 20022 XML reporting standard.
- Adoption of the CPMI-IOSCO Critical Data Elements (CDE).
- Introduction of the Unique Transaction Identifier (UTI) and Unique Product Identifier (UPI).
- Enhanced lifecycle, valuation and collateral reporting.
- Improved data quality, standardisation and international harmonisation.
Rely On Qomply To Help
Start your
Qomply journey
Related Resources
InsightsHKMA Releases Updated Validation Rules in Response to Common Data Quality Issues
InsightsGlobal Transaction Reporting Rewrites Are Forcing Industry Modernisation
UPI Finder | Locate UPIs for ISINs with UPI Finder
ISIN Finder | Locate Reportable ISINs for a UPI
InsightsCommon Regulatory Reporting Failures Across Regions
FAQs: HKMA Transaction Reporting
The HKMA Reporting Rules apply to prescribed entities, including authorised institutions (AIs), licensed corporations (LCs), approved money brokers (AMBs) and certain recognised central counterparties (CCPs). These entities are required to report eligible OTC derivatives transactions in accordance with the HKMA Reporting Rules.
All OTC derivative trades and positions are in scope for HKMA reporting.
In practice, HKMA operates as a dual-sided reporting regime. Where both counterparties are prescribed reporting entities under the HKMA Reporting Rules, each has its own reporting obligation to report eligible OTC derivatives transactions to the HKTR. Firms may appoint a third party to submit reports on their behalf where permitted under the Rules, but responsibility for compliance remains with the reporting entity.
The HKMA Rewrite introduced the ISO 20022 XML reporting standard, the CPMI-IOSCO Critical Data Elements (CDE), the Unique Transaction Identifier (UTI) and the Unique Product Identifier (UPI). It also expanded the reportable data set, enhanced lifecycle, valuation and collateral reporting, and improved data quality through greater alignment with international reporting standards. The changes brought Hong Kong's reporting framework into closer alignment with other major global OTC derivatives reporting regimes.
Reportable OTC derivatives transactions and subsequent lifecycle events must generally be reported to the Hong Kong Trade Repository (HKTR) on a T+2 basis. Daily valuation information and margin and collateral updates are also subject to prescribed reporting timeframes.